More from last Summer: It's never a good sign when you're batting leadoff in this column two weeks in a row. Unfortunately, such is the case for Carlos Beltran, who has been on the DL for more than a week now and does not appear to be coming off anytime soon. Last week in this space, we outlined the injury Beltran was dealing with and speculated that his time away would be extended beyond 15 days. Indeed, that appears to be the case. Beltran made a trek to Vail, Colo., this week to get a second opinion from Dr. Richard Steadman. The choice of Steadman as consultant raised some eyebrows, since his expertise is associated with microfracture surgery, a procedure that he helped pioneer. Although Beltran's agent, Scott Boras, claimed that seeking out Steadman simply represented seeking an independent opinion, you don't take your Ferrari to a Rolls-Royce dealer, even if the latter is accustomed to dealing with high-end automobiles. The Ferrari engine is entrusted to an expert in Ferraris. Beltran is dealing with a bone bruise, an injury often associated with cartilage damage. Microfracture procedures are performed to address cartilage defects. Evaluating cartilage injuries is a critical component of determining when microfracture surgery is indicated. It does not appear to be a coincidence that an athlete with a worsening bone bruise would seek an opinion from another orthopedist well versed in cartilage injuries, especially within the knee. (It should be noted that Mets team physician Dr. David Altchek is very experienced in managing cartilage injuries as well.) The good news? Steadman supported Beltran's original diagnosis of a bone bruise and recommended continued rest and rehabilitation. No microfracture surgery for Beltran (at least not now), which would have effectively ended his season. So why the cause for concern? It's the uncertainty around the resolution of Beltran's condition. How well will Beltran heal, and how long will it take? Just because he's not headed for the operating room doesn't mean we can be certain that he will recover to such a degree that he can play consistently and effectively this year. Although many bone bruises do heal with time and rest, it is not an absolute. The timetable can vary and in a situation like Beltran's, in which the condition has recently worsened, it becomes less predictable. Consider also that Beltran had arthroscopic surgery on both knees in 2007. Beltran underwent debridement of both patellar tendons, the large tendons that cross the kneecap and anchor the quadriceps muscle to the tibia (shinbone). While the two conditions could be independent, it is also possible that some of the biomechanical features of Beltran's knees that led to patellar tendon problems are at work here. The plan now is to keep Beltran moving at a gradual pace, with a target of returning at some point after the All-Star break. Fantasy owners need to bear in mind that this is primarily a symptom-based rehab progression, meaning Beltran's activity will largely be determined by how he feels (although subsequent imaging studies can also provide information as to how the bone bruise itself is progressing). The key for the Mets will be whether Beltran's symptoms can decrease enough and whether enough healing can occur to allow him to return successfully this season. If so, the team may still need to re-evaluate Beltran's status at the end of the season to determine what, if any, steps to take next. http://sports.espn.go.com/espn/blog/index?entryID=4299946&name=bell_stephania